Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 3 Issue: 2, June

Preface [Hot topic: Psoriasis (Guest Editor: Giampiero Girolomoni)]

Volume:3   Issue: 2
Pp: i-i
Giampiero Girolomoni
DOI: 10.2174/1568010043343921
Published on: 01 March, 2012

Epidemiology of Psoriasis

Volume:3   Issue: 2
Pp: 121-128
Luigi Naldi
DOI: 10.2174/1568010043343958
Published on: 01 March, 2012

The Psoriasis Genetics as a Model of Complex Disease

Volume:3   Issue: 2
Pp: 129-136
Emiliano Giardina, Cecilia Sinibaldi and Giuseppe Novelli
DOI: 10.2174/1568010043343877
Published on: 01 March, 2012

Immunopathogenesis of Psoriasis

Volume:3   Issue: 2
Pp: 137-144
Maki Ozawa and Setsuya Aiba
DOI: 10.2174/1568010043343868
Published on: 01 March, 2012

Established Treatments of Psoriasis

Volume:3   Issue: 2
Pp: 145-156
Peter C.M. van de Kerkhof and Wijnand H.P.M. Vissers
DOI: 10.2174/1568010043343967
Published on: 01 March, 2012

T-Cell-Targeted Biologicals for Psoriasis

Volume:3   Issue: 2
Pp: 157-161
Christopher E.M. Griffiths
DOI: 10.2174/1568010043343912
Published on: 01 March, 2012

Targeting Selectin Functions in the Therapy of Psoriasis

Volume:3   Issue: 2
Pp: 163-168
Michael P. Schon, Claudia Drewniok and W. -Henning Boehncke
DOI: 10.2174/1568010043343895
Published on: 01 March, 2012

Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis

Volume:3   Issue: 2
Pp: 169-174
Bernhard Homey
DOI: 10.2174/1568010043343840
Published on: 01 March, 2012

Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis

Volume:3   Issue: 2
Pp: 175-183
Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni
DOI: 10.2174/1568010043343903
Published on: 01 March, 2012

Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis

Volume:3   Issue: 2
Pp: 185-192
Khusru Asadullah, Robert Sabat, Markus Friedrich, Hans Dieter Volk and Wolfram Sterry
DOI: 10.2174/1568010043343886
Published on: 01 March, 2012

Immune Deviation Strategies in the Therapy of Psoriasis

Volume:3   Issue: 2
Pp: 193-198
Kamran Ghoreschi and Martin Rocken
DOI: 10.2174/1568010043343949
Published on: 01 March, 2012

New Vitamin D Analogs in Psoriasis

Volume:3   Issue: 2
Pp: 199-204
Karsten Fogh and Knud Kragballe
DOI: 10.2174/1568010043343930
Published on: 01 March, 2012

Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis

Volume:3   Issue: 2
Pp: 205-211
Stephane Kuenzli and Jean-Hilaire Saurat
DOI: 10.2174/1568010043343976
Published on: 01 March, 2012

Histone Deacetylase Inhibitors in Psoriasis Therapy

Volume:3   Issue: 2
Pp: 213-219
Fiona McLaughlin and Nicholas B. La Thangue
DOI: 10.2174/1568010043343859
Published on: 01 March, 2012